The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
Open accessAbstract
The androgen receptor (AR) remains functionally important in the development and progression of prostate cancer even when the disease seems androgen "independent." Because signal transduction by growth factor receptors increases in advanced prostate cancer and is capable of sensitizing the AR to androgen, there is considerable interest in determining the mechanisms by which signaling systems can modulate AR function. We show herein that the adaptor/scaffolding protein receptor for activated C kinase 1 (RACK1), which was previously reported to interact with the AR, modulates the tyrosine phosphorylation of AR and its interaction with the Src tyrosine kinase. We also show that down-regulation of RACK1 by short interfering RNA inhibits growth and stimulates prostate-specific antigen transcription in androgen-treated prostate cancer cells. Our results suggest that RACK1 mediates the cross-talk of AR with additional binding partners, such as Src, and facilitates the tyrosine phosphorylation and transcriptional activity of the AR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activity of Src on AR transactivation is modulated, at least in part, through its binding partner and associated scaffolding protein receptor for activated C kinase 1 (RACK1) (43).”
From Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer (2011) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wong, C., McNally, C., Nickbarg, E., Komm, B. S., & Cheskis, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192569699 · Cited by 321
RetractedSequence and structure-based prediction of eukaryotic protein phosphorylation sites
Blom, N., Gammeltoft, S., & Brunak, S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3310 · Cited by 3,212
Dorit Ron, A., Chen, C., Caldwell, J., Jamieson, L., Orr, E., & Mochly‐Rosen, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.839 · Cited by 723
Migliaccio, A., Castoria, G., Domenico, M. D., de Falco, A., Bilancio, A., Lombardi, M., Barone, M. V., Ametrano, D., Zannini, M. S., Abbondanza, C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5406 · Cited by 672
Migliaccio, A., Piccolo, D., Castoria, G., Domenico, M. D., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 627
Yeh, S., Lin, H., Kang, H., Thin, T. H., Lin, M., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594
Boonyaratanakornkit, V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., & Edwards, D. P. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00304-5 · Cited by 590
Kemppainen, J., Lane, M. V., Sar, M., & Wilson, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48380-9 · Cited by 430
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
The RACK1 Scaffold Protein: A Dynamic Cog in Cell Response Mechanisms
McCahill, A., Warwicker, J., Bolger, G. B., Houslay, M. D., & Yarwood, S. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1261 · Cited by 386
Regulation of androgen receptor activity by tyrosine phosphorylation.
Guo, Z., Dai, B., Jiang, T., Xu, K., Xie, Y., Kim, O., Nesheiwat, I., Kong, X., Melamed, J., Handratta, V. D., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.021 · Cited by 364
Androgen Receptor Phosphorylation
Gioeli, D. G., Ficarro, S. B., Kwiek, J. J., Aaronson, D. S., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 355
Self-citationRack1, a Receptor for Activated Protein Kinase C, Interacts with Integrin β Subunit
Liliental, J., & Chang, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2379 · Cited by 346
Yarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D., & Bolger, G. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14909 · Cited by 306
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Tyagi, R. K., Lavrovsky, Y., Ahn, S., Song, C. S., Chatterjee, B., & Roy, A. K. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0497 · Cited by 291
Nuclear import of the human androgen receptor
Jenster, G. W., Trapman, J., & Brinkmann, A. O. (1993) · Biochemical Journal · doi:10.1042/bj2930761 · Cited by 273
Chang, B. Y., Conroy, K. B., Machleder, E. M., & Cartwright, C. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3245 · Cited by 260
Physiological role for the cochaperone FKBP52 in androgen receptor signaling
Cheung-Flynn, J., Prapapanich, V., Cox, M. B., Riggs, D. L., Suarez-Quian, C., & Smith, D. F. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0071 · Cited by 212
Hermanto, U., Zong, C. S., Li, W., & Wang, L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2345-2365.2002 · Cited by 201
Georget, V., Lobaccaro, J. A., Térouanne, B., Mangeat, P. H., Nicolas, J., & Sultan, C. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04034-3 · Cited by 193
Binding Specificity for RACK1 Resides in the V5 Region of βII Protein Kinase C
Stebbins, E. G., & Mochly‐Rosen, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101044200 · Cited by 183
Chang, B. Y., Chiang, M., & Cartwright, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101375200 · Cited by 177
Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrc
Barletta, F., Wong, C.-W., McNally, C., Komm, B. S., Katzenellenbogen, B. S., & Cheskis, B. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0335 · Cited by 175
Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization
Gioeli, D. G., Black, B. E., Gordon, V. L., Spencer, A., Kesler, C. T., Eblen, S. T., Paschal, B. M., & Weber, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0351 · Cited by 175
Self-citationContribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015531326689 · Cited by 165
Recent advances in androgen receptor action
Lee, H.-J., & Chang, C. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2309-3 · Cited by 162
Hsp90 as a therapeutic target in prostate cancer
Solit, D. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00346-4 · Cited by 140
Cox, E. A., Bennin, D. A., Doan, A. T., O’Toole, T. E., & Anna Huttenlocher, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-03-0142 · Cited by 139
Androgen Receptor Cross-talk with Cell Signalling Pathways
Čulig, Z. (2004) · Growth Factors · doi:10.1080/08977190412331279908 · Cited by 137
RACK1 IS UP‐REGULATED IN ANGIOGENESIS AND HUMAN CARCINOMAS
Berns, H., Humar, R., Hengerer, B., Kiefer, F. N., & Battegay, E. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-1038com · Cited by 119
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 117
Self-citationArnold, S. F., Melamed, M., Vorojeikina, D. P., Notides, A. C., & Sasson, S. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9876 · Cited by 113
Vomastek, T., Schaeffer, H. J., Tarcsafalvi, A., Smolkin, M. E., Bissonette, E. A., & Weber, M. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305894101 · Cited by 109
Self-citationThe WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration
Buensuceso, C. S., Woodside, D. G., Huff, J. L., Plopper, G. E., & O’Toole, T. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.9.1691 · Cited by 108
Усачева, А. М., Smith, R. L., Minshall, R. D., Baida, G. E., Seng, S., Croze, E., & Colamonici, O. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100087200 · Cited by 88
RACK1 Regulates G1/S Progression by Suppressing Src Kinase Activity
Mamidipudi, V., Zhang, J., Lee, K. C., & Cartwright, C. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6788-6798.2004 · Cited by 77
Rigas, A. C., Ozanne, D. M., Neal, D. E., & Robson, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306219200 · Cited by 64
Kuiper, G. G. J. M., & Brinkmann, A. O. (1995) · Biochemistry · doi:10.1021/bi00006a005 · Cited by 59
Haas, D., White, S., Lutz, L. B., Rasar, M., & Hammes, S. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0531 · Cited by 59
RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling
Miller, L. D., Lee, K. C., Mochly‐Rosen, D., & Cartwright, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207735 · Cited by 41
Characterization of MNAR expression
Greger, J., Guo, Y., Henderson, R. A., Ross, J. F., & Cheskis, B. J. (2005) · Steroids · doi:10.1016/j.steroids.2005.09.016 · Cited by 31
Cited by
Sorted by citations
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M.-H., Li, J., Xu, H. E., Melcher, K., & Yong, E. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 1,000
Molecular genetics of prostate cancer: new prospects for old challengesPreprint
Shen, M. M., & Abate-Shen, C. T. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 991
Harris, W. P., Mostaghel, E. A., Nelson, P. S., & Montgomery, B. (2009) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1296 · Cited by 880
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vicković, S., Larsson, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04724-5 · Cited by 558
Metadata
- Authors
- Kraus, S., Gioeli, D., Vomastek, T., Gordon, V., & Weber, M. J.
- Affiliations
- University of Virginia Health System (US)
- Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia
- Venue
- Cancer Research
- Published
- 2006-11-15
- Volume
- 66
- Issue
- 22
- Pages
- 11047-11054
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2142284564
- Cited by
- 118
- References
- 42
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 5 · 2012: 5
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH)
- Prostate Cancer Foundation
- National Institutes of Health (W81XWH)
- National Cancer Institute (R01CA105402, P01CA104106)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, RACK1, Src kinase, tyrosine phosphorylation, prostate cancer, castration-resistant prostate cancer, adaptor proteins, signal transduction, growth factor receptor signaling, transcriptional activity
- MeSH terms
- Receptors for Activated C Kinase, Androgens, Animals, Chlorocebus aethiops, Humans, Male, Phosphorylation, Prostatic Neoplasms, Receptors, Androgen, Receptors, Cell Surface, Substrate Specificity, Signal Transduction, Disease Progression, src-Family Kinases, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review